Industry News
New mouse model finds two genes behind most severe form of ovarian cancer
1/28/2015
Not all mouse models of ovarian cancer give a true picture of the human disease. Now, a new model of the most severe form may open routes to better treatments and diagnostics.
Phase I/II clinical trial in second-line lower risk myelodysplastic syndrome with OPN-305 initiated
1/28/2015
Opsona Therapeutics Ltd, the innate immune drug development company focused on novel therapeutic approaches to treat autoimmune, inflammatory diseases and oncology, announces that it has initiated...
New mouse model finds two genes behind most severe form of ovarian cancer
1/28/2015
Not all mouse models of ovarian cancer give a true picture of the human disease. Now, a new model of the most severe form may open routes to better treatments and diagnostics.
Cancer specialist proposes ten point plan to cut 10,000 unnecessary cancer deaths in the UK
1/28/2015
One of Britain's leading Consultant Oncologists claims that a staggering 10,000 deaths per year are caused by the NHS's failure to treat cancer patients fast enough and he has drawn up a ten point...
Blood transfusions during heart surgery increase risk of pneumonia
1/28/2015
Patients who receive red blood cell transfusions during coronary artery bypass grafting (CABG) surgery are at an increased risk of developing pneumonia, according to an abstract released at the...
High-risk prostate cancers 'better detected' using targeted biopsy
1/28/2015
Researchers find a targeted biopsy method that combines ultrasound and MRI is more effective for identifying high-risk prostate cancers than the standard biopsy technique.
Death rates from lung cancer will overtake those for breast cancer in 2015 among EU women
1/28/2015
Death rates from lung cancer will exceed those for breast cancer for the first time among European women in 2015, according to the latest predictions published in the leading cancer journal Annals of...
Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs).
Targeted biopsy 'better at detecting high-risk prostate cancers than standard biopsy'
1/28/2015
Researchers find a targeted biopsy method that combines ultrasound and MRI is more effective for identifying high-risk prostate cancers than the standard biopsy technique.
Mayo Clinic: New breast cancer risk prediction model more accurate than current model
1/28/2015
A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately...